AIM Vaccine Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-831.00
-315.00
-2,509.00
-504.00
-731.00
545.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
36.00
151.00
123.00
-102.00
-397.00
-426.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
36.00
55.00
-217.00
-160.00
110.00
230.00
Cash Flow from Investing Activities
-163.00
-184.00
-284.00
-989.00
-1,624.00
-1,257.00
Cash Flow from Financing Activities
-58.00
37.00
453.00
1,151.00
962.00
1,873.00
Net Cash Inflow / Outflow
-184.00
-90.00
-46.00
-1.00
-552.00
846.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
2.00
-2.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of AIM Vaccine Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-831.348981491024
11766.6469320389
-12,597.00
-107.07%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
36.714369669073
-232.623755879779
268.00
115.78%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
36.495295948187
10630.9318891714
-10,594.00
-99.66%
Cash Flow from Investing Activities
-163.304275593301
-2212.75737137886
2,049.00
92.62%
Cash Flow from Financing Activities
-58.168410988708
2615.01251219673
-2,673.00
-102.22%
Net Cash Inflow / Outflow
-184.739880015634
10865.8971310086
-11,049.00
-101.70%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.237510618188255
-167.289898980706
167.00
100.14%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -34.41% vs 125.58% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
36.50
55.64
-34.41%






